Review of genetic risk variants in idiopathic pulmonary fibrosis among non-European individuals shows limited transferability.

This publication is a review evaluating genetic risk variants in the context of idiopathic pulmonary fibrosis. The scope is restricted to clinically curated non-European individuals, acknowledging that the sample size is limited. The authors do not report specific adverse events or primary outcomes, focusing instead on the genetic architecture within this understudied population.

The key synthesized findings indicate a partial replication of genetic risk variants and limited transferability of some variants across the studied groups. Evidence of ancestry-specific effects was observed, distinguishing these findings from broader patterns. The MUC5B promoter variant rs35705950 emerged as a dominant signal across ancestries, suggesting a consistent biological marker despite other limitations.

The authors note that limited sample sizes constrain the ability to draw definitive conclusions. Consequently, the practice relevance is framed as a need for larger, well-characterized studies in understudied populations to support robust discovery and translation. No safety data, discontinuations, or tolerability were reported in this evaluation.